Lv6
1900 积分 2020-09-22 加入
Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment
4天前
已完结
Radiotherapy opens the blood–brain barrier and synergizes with anlotinib in treating glioblastoma
4天前
已完结
Comparison of the efficacy and safety of anlotinib monotherapy or anlotinib plus immune checkpoint inhibitor for advanced small cell lung cancer with brain metastases
8天前
已完结
Radiotherapy opens the blood–brain barrier and synergizes with anlotinib in treating glioblastoma
8天前
已完结
Cancer burden and control in China: landscape, trends and challenges
18天前
已完结
Cancer incidence and mortality in China, 2022
18天前
已完结
First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer
1个月前
已完结
Comparison of the Efficacy and Safety of Perioperative Immunochemotherapeutic Strategies for Resectable Non-small Cell Lung Cancer: a Systematic Review and Network Meta-analysis
1个月前
已完结
Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis
1个月前
已完结
Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer
1个月前
已完结
皖公网安备34019202002308
